1.31
前日終値:
$1.23
開ける:
$1.23
24時間の取引高:
116.35K
Relative Volume:
0.33
時価総額:
$8.74M
収益:
$5.64M
当期純損益:
$-23.88M
株価収益率:
-2.4717
EPS:
-0.53
ネットキャッシュフロー:
$-22.36M
1週間 パフォーマンス:
+15.67%
1か月 パフォーマンス:
+31.59%
6か月 パフォーマンス:
-24.28%
1年 パフォーマンス:
-79.85%
Evogene Ltd Stock (EVGN) Company Profile
EVGN を他の銘柄と比較する
株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
---|---|---|---|---|---|---|
![]()
EVGN
Evogene Ltd
|
1.31 | 7.56M | 5.64M | -23.88M | -22.36M | -0.53 |
![]()
ONC
Beigene Ltd Adr
|
228.38 | 25.07B | 3.81B | -644.79M | -669.77M | -6.24 |
![]()
VRTX
Vertex Pharmaceuticals Inc
|
438.65 | 109.14B | 11.10B | -988.90M | -1.26B | -3.92 |
![]()
AKTX
Akari Therapeutics Plc Adr
|
1.27 | 36.39M | 0 | 0 | 0 | 0.00 |
![]()
REGN
Regeneron Pharmaceuticals Inc
|
594.32 | 56.98B | 14.09B | 4.50B | 2.96B | 39.28 |
![]()
VRNA
Verona Pharma Plc Adr
|
71.31 | 5.39B | 0 | -153.72M | -103.81M | -2.00 |
Evogene Ltd Stock (EVGN) Upgrades & Downgrades
日付 | アクション | アナリスト | 評価の変更 |
---|---|---|---|
2021-10-08 | 開始されました | ROTH Capital | Buy |
2021-07-29 | 開始されました | Aegis Capital | Buy |
2020-12-01 | 開始されました | Cantor Fitzgerald | Overweight |
2013-12-16 | 開始されました | Oppenheimer | Outperform |
Evogene Ltd (EVGN) 最新ニュース
StockNews.com Begins Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene (EVGN) Projected to Post Quarterly Earnings on Wednesday - Defense World
Evogene Schedules First Quarter 2025 Financial Results Release - Krishak Jagat
Casterra Announces Additional $2.2 Million of Purchase Orders to Supply Castor Seeds for New African Territories - Barchart.com
Evogene Announces Pricing Of US$8,500,000 Registered Direct Offering - Barchart.com
Evogene (NASDAQ:EVGN) Coverage Initiated by Analysts at StockNews.com - Defense World
Evogene (NASDAQ:EVGN) Now Covered by Analysts at StockNews.com - Defense World
Biotech Alert: Searches spiking for these stocks today - TipRanks
Industry News: Minnesota Co-Op Names Next CEO, ICL Acquires Lavie Bio - thedailyscoop.com
Why Evogene Ltd. (EVGN) Soared on Monday - MSN
Stocks in Oversold Territory: EVGN, MLGO, PRSO, SHFSMore Undervalued Players Worth Watching Inside - openPR.com
10 Micro-, Small-Cap Companies Lead Monday’s Charge - Insider Monkey
ICL acquires Evogene subsidiary Lavie Bio By Investing.com - Investing.com South Africa
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio and MicroBoost AI - Benzinga
Evogene Stock Soars After ICL Deal To Acquire Lavie Bio, MicroBoost AIEvogene (NASDAQ:EVGN) - Benzinga
Minerals Giant ICL to Acquire AI-Driven Ag Tech Company Lavie Bio - AgriBusiness Global
Evogene To Sell Majority Of Lavie Bio To ICL For Undisclosed Terms - Nasdaq
ICL acquires Evogene subsidiary Lavie Bio - Investing.com Australia
Evogene Announces Sale of Lavie Bio’s Assets to ICL - TipRanks
ICL to Acquire the Activity of Evogene's Subsidiary, Lavie Bio - Nasdaq
Evogene (NASDAQ:EVGN) Share Price Crosses Below 200-Day Moving Average – Should You Sell? - Defense World
Evogene (NASDAQ:EVGN) Coverage Initiated at StockNews.com - Defense World
Evogene stock hits 52-week low at $0.99 amid market challenges By Investing.com - Investing.com South Africa
Evogene Schedules Third Quarter 2024 Financial Results Release - marketscreener.com
Evogene stock hits 52-week low at $0.99 amid market challenges - Investing.com Australia
Biomica CEO Set to Engage in Panel Discussion at 8th Annual Euro - GuruFocus
Evogene stock hits 52-week low at $1.18 amid market challenges - Investing.com Canada
Evogene stock hits 52-week low at $1.18 amid market challenges By Investing.com - Investing.com South Africa
Evogene Ltd. (NASDAQ:EVGN) Sees Significant Decline in Short Interest - The AM Reporter
Evogene (NASDAQ:EVGN) Share Price Passes Below 200 Day Moving Average – What’s Next? - Defense World
StockNews.com Initiates Coverage on Evogene (NASDAQ:EVGN) - Defense World
Evogene Announces Expected Implementation of 1-for-10 Reverse Share Split - Marketscreener.com
Evogene Announces Filing of Annual Report on Form 20-F - GuruFocus.com
AgPlenus Announces Discovery of a New Mode of Action for Fungici - GuruFocus.com
Evogene Ltd. Earnings Call: Growth Amid Challenges - TipRanks
Evogene Ltd. (NASDAQ:EVGN) Q4 2024 Earnings Call Transcript - Insider Monkey
Evogene price target lowered to $6 from $11.25 at Alliance Global Partners - TipRanks
Evogene: Q4 Earnings Snapshot - Barchart
Evogene Ltd to Host Earnings Call - ACCESS Newswire
Evogene Ltd (EVGN) Q4 2024 Earnings Call Highlights: Revenue Growth and Strategic ... - Yahoo Finance
Evogene Ltd. (NASDAQ:EVGN) Short Interest Up 22.1% in February - Defense World
Evogene Announces the Appointment of Nir Nimrodi as the New Chairperson of the Board, Effective March 5, 2025 - StreetInsider.com
Evogene Ltd. Reports Revenue Growth and Strategic Focus - TipRanks
Evogene Reports Fourth Quarter and Full Year 2024 Financial Results - The Malaysian Reserve
Earnings call transcript: Evogene Q4 2024 beats EPS forecast, misses revenue - Investing.com
Evogene Ltd reports results for the quarter ended December 31Earnings Summary - TradingView
Evogene reports Q4 EPS 6c vs. ($1.30) last year - TipRanks
Evogene Ltd (EVGN) 財務データ
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):